Biotechnology company Allarity Therapeutics Inc recently filed documents with the U.S. Securities and Exchange Commission, disclosing that its selling shareholders plan to resell 255,103 shares of the company’s common stock.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The scale of the compute power agreement between Anthropic and SpaceX has been revealed, reaching up to $84.5 billions, double the previously disclosed amount.
According to Anthropic’s IPO prospectus, the company has signed a computing power leasing agreement with SpaceX valued at $84.5 billion, far surpassing the previously disclosed $45 billion in SpaceX’s IPO documents. The agreement runs until 2029, with most terms cancellable within 90 days. At the same time, Anthropic’s total spending on AI infrastructure over the next decade is expected to be at least $518 billion.
KOSPI Index in South Korea falls by 0.3%
Canadian Dollar remains subdued near two-month lows as falling oil prices weigh
Jamie Dimon Says the Dollar Only Stays Dominant if the US Makes Trade Deals
Crypto prices
More
